METHYL 4-BROMOBICYCLO[2.2.2]OCTANE-1-CARBOXYLATE, 95.0%, 250mg

4-chloro-6-(4-chlorophenyl)pyrimidine, 95.0%, 1g

1-(((2R,3S)-2-(2,4-DIFLUOROPHENYL)-3-METHYLOXIRAN-2-YL)METHYL)-1H-1,2,4-TRIAZOLE, 97.0%, 25g

1,2,4-Oxadiazole-3-carbothioamide, 95.0%, 5g

8,8-Dimethyl-7-oxo-2-azaspiro[3.5]non-5-ene-6-carbonitrile hydrochloride, 98%, 250mg

1,4-Dihydronaphthalene, 97%, 250mg

(4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone, 95.0%, 1g

3-(4-AMINOPHENYL)-1,1,3-TRIMETHYL-2,3-DIHYDRO-1H-INDEN-5-AMINE, 95%, 5g

GC-Kapillarsäule ROTI®Cap-35 MS, L 30 m, Ø-Innen 0,32 mm, Filmd. 0,25 µm, 1 Stück

4-Chloro-3-trifluoromethylphenylboronic acid, 96.0%, 500g

ethyl (2Z)-2-chloro-2-[2-(4-fluorophenyl)hydrazin-1-ylidene]acetate, 95.0%, 10g

2,4-DIBROMOBENZAMIDE, 95.0%, 250mg

2-(4-FLUORO-TETRAHYDRO-PYRAN-4-YL)-BENZONITRILE, 95.0%, 250mg